US FDA approves use of Emergent's smallpox vaccine for people at high risk of mpox

Emergent BioSolutions

30/08/2024 24:18

Aug 29 (Reuters) - Emergent BioSolutions  EBS.N  on
Thursday said the U.S. Food and Drug Administration (FDA) had
approved expanded use of its ACAM2000 smallpox vaccine to
include people at high risk for mpox infection. 

 (Reporting by Shivani Tanna in Bengaluru; Editing by Maju
Samuel)
 ((ShivaniJayesh.Tanna@thomsonreuters.com;))